BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29249059)

  • 1. Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment.
    River J; McKenzie H; Levy D; Pavlakis N; Back M; Oh B
    Support Care Cancer; 2018 Jun; 26(6):1791-1797. PubMed ID: 29249059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.
    Smith CA; Hunter J; Delaney GP; Ussher JM; Templeman K; Grant S; Oyston E
    BMC Complement Altern Med; 2018 Oct; 18(1):289. PubMed ID: 30373631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: A scoping study.
    Lim E; Vardy JL; Oh B; Dhillon HM
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):6-12. PubMed ID: 27782378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating complementary and alternative medicine into mainstream healthcare services: the perspectives of health service managers.
    Singer J; Adams J
    BMC Complement Altern Med; 2014 May; 14():167. PubMed ID: 24885066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of traditional, complementary and alternative medicine among conventional healthcare practitioners in Accra, Ghana: Implications for integrative healthcare.
    Kretchy IA; Okere HA; Osafo J; Afrane B; Sarkodie J; Debrah P
    J Integr Med; 2016 Sep; 14(5):380-8. PubMed ID: 27641609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.
    Corina G; Christine H; Klein G
    Support Care Cancer; 2016 Sep; 24(9):3857-62. PubMed ID: 27075675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Themes of holism, empowerment, access, and legitimacy define complementary, alternative, and integrative medicine in relation to conventional biomedicine.
    Barrett B; Marchand L; Scheder J; Plane MB; Maberry R; Appelbaum D; Rakel D; Rabago D
    J Altern Complement Med; 2003 Dec; 9(6):937-47. PubMed ID: 14736364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining research priorities in complementary medicine in oncology.
    Robotin M; Holliday C; Bensoussan A
    Complement Ther Med; 2012 Oct; 20(5):345-52. PubMed ID: 22863650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication and integration: a qualitative analysis of perspectives among Middle Eastern oncology healthcare professionals on the integration of complementary medicine in supportive cancer care.
    Ben-Arye E; Popper-Giveon A; Samuels N; Mutafoglu K; Schiff E; Omran S; Charalambous H; Dweikat T; Ghrayeb I; Turker I; Hassan A; Hassan E; Nimri O; Kebudi R; Silbermann M
    J Cancer Res Clin Oncol; 2016 May; 142(5):1117-26. PubMed ID: 26833203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing Complementary and Alternative Medicine in primary care: the primary care workers' perspective.
    van Haselen RA; Reiber U; Nickel I; Jakob A; Fisher PA
    Complement Ther Med; 2004 Mar; 12(1):6-16. PubMed ID: 15130567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explore the use of complementary and alternative medicine among Chinese gynaecological patients with cancer undergoing chemotherapy: a qualitative phenomenological study.
    Zhang J; Luo B; Liu X; He Y; Zuo Y
    BMJ Open; 2023 Dec; 13(12):e074313. PubMed ID: 38114285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis.
    Correa-Velez I; Clavarino A; Eastwood H
    J Palliat Med; 2005 Oct; 8(5):953-61. PubMed ID: 16238508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informing the model of care for an academic integrative healthcare centre: a qualitative study exploring healthcare consumer perspectives.
    Ee C; Templeman K; Grant S; Avard N; de Manincor M; Hunter J
    BMC Complement Med Ther; 2020 Feb; 20(1):58. PubMed ID: 32070328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I will always be with you: traditional and complementary therapists' perspectives on patient-therapist-doctor communication regarding treatment of Arab patients with cancer in Israel.
    Popper-Giveon A; Schiff E; Ben-Arye E
    Patient Educ Couns; 2012 Dec; 89(3):381-6. PubMed ID: 22534661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis.
    Pelletier KR; Astin JA
    Altern Ther Health Med; 2002; 8(1):38-9, 42, 44 passim. PubMed ID: 11795621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing Unmet Information Needs: Results of a Clinician-Led Consultation Service About Complementary and Alternative Medicine for Cancer Patients and Their Relatives.
    Horneber M; van Ackeren G; Fischer F; Kappauf H; Birkmann J
    Integr Cancer Ther; 2018 Dec; 17(4):1172-1182. PubMed ID: 30352519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative medicine models in contemporary primary health care.
    Templeman K; Robinson A
    Complement Ther Med; 2011 Apr; 19(2):84-92. PubMed ID: 21549259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
    Salamonsen A
    Eur J Public Health; 2016 Apr; 26(2):225-9. PubMed ID: 26450914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.